SideROS
SideROS aims to tackle relapse and metastasis by targeting persister cancer cells with a small molecule, the ironomycin, disturbing iron metabolism and eliminating those cells through ferroptosis.
1 Clos de la Marquise, Chatillon, IdF 92320, France
Phone: 606123425
Email: lucie.mondoulet@sideros.bio